Fife, M.; Tong, M.; Das, B.; Rodriguez, R.; Chokkalingam, P.; Carlson, R.I.; de la Monte, S.M.
Chondrosarcoma: Multi-Targeting Therapeutic Effects of Doxorubicin, BEZ235, and the Small Molecule Aspartyl-Asparaginyl-β-hydroxylase Inhibitor SMI1182. Cancers 2025, 17, 1671.
https://doi.org/10.3390/cancers17101671
AMA Style
Fife M, Tong M, Das B, Rodriguez R, Chokkalingam P, Carlson RI, de la Monte SM.
Chondrosarcoma: Multi-Targeting Therapeutic Effects of Doxorubicin, BEZ235, and the Small Molecule Aspartyl-Asparaginyl-β-hydroxylase Inhibitor SMI1182. Cancers. 2025; 17(10):1671.
https://doi.org/10.3390/cancers17101671
Chicago/Turabian Style
Fife, Megan, Ming Tong, Bhaskar Das, Rene Rodriguez, Parthiban Chokkalingam, Rolf I. Carlson, and Suzanne M. de la Monte.
2025. "Chondrosarcoma: Multi-Targeting Therapeutic Effects of Doxorubicin, BEZ235, and the Small Molecule Aspartyl-Asparaginyl-β-hydroxylase Inhibitor SMI1182" Cancers 17, no. 10: 1671.
https://doi.org/10.3390/cancers17101671
APA Style
Fife, M., Tong, M., Das, B., Rodriguez, R., Chokkalingam, P., Carlson, R. I., & de la Monte, S. M.
(2025). Chondrosarcoma: Multi-Targeting Therapeutic Effects of Doxorubicin, BEZ235, and the Small Molecule Aspartyl-Asparaginyl-β-hydroxylase Inhibitor SMI1182. Cancers, 17(10), 1671.
https://doi.org/10.3390/cancers17101671
